Therapeutical Aspects of Cerebrovascular Disease
- 1 January 1983
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 22 (1) , 74-77
- https://doi.org/10.1159/000115653
Abstract
Treatment of hemorheologic alterations in patients with CVD must be directed to reduce enhanced platelet and red cell aggregation, to improve reduced red cell deformability, and to control plasmatic hypercoagulability.Keywords
This publication has 0 references indexed in Scilit: